Moreover, the majority (66.2%) of the Npas4 shRNA-downregulated genes from our analysis overlapped with upregulated genes in human MDD patients (Figure 5F), suggesting that Npas4 expression could contribute to vulnerability to depression in the human brain. The gene discussed is NPAS4; the disease is depressive disorder.